...
首页> 外文期刊>BMC Infectious Diseases >Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study
【24h】

Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study

机译:术前口服抗生素预防减少选择性结直肠手术后的铜绿假单胞菌手术部位感染:一项多中心前瞻性队列研究

获取原文

摘要

Healthcare-associated infections caused by Pseudomonas aeruginosa are associated with poor outcomes. However, the role of P. aeruginosa in surgical site infections after colorectal surgery has not been evaluated. The aim of this study was to determine the predictive factors and outcomes of surgical site infections caused by P. aeruginosa after colorectal surgery, with special emphasis on the role of preoperative oral antibiotic prophylaxis. We conducted an observational, multicenter, prospective cohort study of all patients undergoing elective colorectal surgery at 10 Spanish hospitals (2011–2014). A logistic regression model was used to identify predictive factors for P. aeruginosa surgical site infections. Out of 3701 patients, 669 (18.1%) developed surgical site infections, and 62 (9.3%) of these were due to P. aeruginosa. The following factors were found to differentiate between P. aeruginosa surgical site infections and those caused by other microorganisms: American Society of Anesthesiologists’ score III–IV (67.7% vs 45.5%, p?=?0.001, odds ratio (OR) 2.5, 95% confidence interval (95% CI) 1.44–4.39), National Nosocomial Infections Surveillance risk index 1–2 (74.2% vs 44.2%, p??0.001, OR 3.6, 95% CI 2.01–6.56), duration of surgery ≥75thpercentile (61.3% vs 41.4%, p?=?0.003, OR 2.2, 95% CI 1.31–3.83) and oral antibiotic prophylaxis (17.7% vs 33.6%, p?=?0.01, OR 0.4, 95% CI 0.21–0.83). Patients with P. aeruginosa surgical site infections were administered antibiotic treatment for a longer duration (median 17?days [interquartile range (IQR) 10–24] vs 13d [IQR 8–20], p?=?0.015, OR 1.1, 95% CI 1.00–1.12), had a higher treatment failure rate (30.6% vs 20.8%, p?=?0.07, OR 1.7, 95% CI 0.96–2.99), and longer hospitalization (median 22?days [IQR 15–42] vs 19d [IQR 12–28], p?=?0.02, OR 1.1, 95% CI 1.00–1.17) than those with surgical site infections due to other microorganisms. Independent predictive factors associated with P. aeruginosa surgical site infections were the National Nosocomial Infections Surveillance risk index 1–2 (OR 2.3, 95% CI 1.03–5.40) and the use of oral antibiotic prophylaxis (OR 0.4, 95% CI 0.23–0.90). We observed that surgical site infections due to P. aeruginosa are associated with a higher National Nosocomial Infections Surveillance risk index, poor outcomes, and lack of preoperative oral antibiotic prophylaxis. These findings can aid in establishing specific preventive measures and appropriate empirical antibiotic treatment.
机译:铜绿假单胞菌引起的医疗保健相关感染与不良预后相关。然而,尚未评估铜绿假单胞菌在结直肠手术后在手术部位感染中的作用。这项研究的目的是确定大肠癌手术后由铜绿假单胞菌引起的手术部位感染的预测因素和结果,特别强调术前口服抗生素预防的作用。我们对西班牙10所医院(2011-2014年)接受结直肠癌择期手术的所有患者进行了一项观察性,多中心,前瞻性队列研究。使用逻辑回归模型确定铜绿假单胞菌手术部位感染的预测因素。在3701名患者中,有669名(18.1%)发生了手术部位感染,其中62名(9.3%)是由铜绿假单胞菌引起的。发现以下因素可区分铜绿假单胞菌手术部位感染和其他微生物引起的感染:美国麻醉医师学会评分III–IV(67.7%vs 45.5%,p?=?0.001,优势比(OR)2.5, 95%置信区间(95%CI)1.44–4.39),国家医院感染监测风险指数1-2(74.2%vs 44.2%,p <0.001,或3.6,95%CI 2.01-6.56),手术时间≥75%(61.3%vs 41.4%,p <= 0.003,或2.2,95%CI 1.31-3.83)和口服抗生素预防(17.7%vs 33.6%,p <= 0.01,或0.4,95%CI 0.21- 0.83)。铜绿假单胞菌手术部位感染的患者接受了更长的抗生素治疗时间(中位17天[四分位间距(IQR)10-24]比13天[IQR 8-20],p?= 0.015,或1.1、95 %CI 1.00–1.12),更高的治疗失败率(30.6%vs 20.8%,p?=?0.07或1.7,95%CI 0.96–2.99)和更长的住院时间(中位数22天[IQR 15-42] ] vs 19d [IQR 12–28],p?=?0.02,或1.1,95%CI 1.00–1.17)。与铜绿假单胞菌手术部位感染相关的独立预测因素是美国国家医院感染监测风险指数1-2(OR 2.3,95%CI 1.03-5.40)和口服抗生素的预防使用(OR 0.4,95%CI 0.23-0.90) )。我们观察到,由于铜绿假单胞菌引起的手术部位感染与较高的国家医院感染监测风险指数,不良的预后和缺乏术前口服抗生素的预防有关。这些发现可以帮助建立具体的预防措施和适当的经验性抗生素治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号